Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
【発明の名称】ピルビン酸デヒドロゲナーゼの阻害剤としてのアミド
Document Type and Number:
Japanese Patent JP2003508509
Kind Code:
A
Abstract:
A compound of formula (I):wherein:Ring A is a nitrogen linked mono or bicyclic heterocyclic ring as defined within;R<1 >and R<2 >are independently C1-3alkyl optionally substituted by fluoro or chloro;or R<1 >and R<2 >together with the carbon atom to which they are attached, form a C3-5cycloalkyl ring optionally substituted by fluoro;R<3 >is defined within; andn is 0-5; wherein the values of R<3 >may be the same or different;or a pharmaceutically acceptable salt or an in vivo hydrolysable ester thereof is described. The use of compounds of formula (I) in the production of an elevation of PDH activity in a warm-blooded animal such as a human being are also described. Pharmaceutical compositions, methods and processes for preparation of compounds of formula (I) are detailed.

Inventors:
Batlin, Roger John
Peace, Janet Elizabeth
Brock, Michael Howard
Nowak, Toasten
Brows, Jeremy Nicholas
Clarke, david stephen
Application Number:
JP2001521689A
Publication Date:
March 04, 2003
Filing Date:
August 30, 2000
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
AstraZeneca Activrag
International Classes:
C07D295/18; A61K31/404; A61K31/4468; A61K31/495; A61P3/06; A61P3/10; A61P9/10; C07D209/08; C07D211/32; C07D211/58; C07D241/04; C07D295/185; C07D295/192; C07D295/22; C07D295/26; (IPC1-7): C07D209/08; A61K31/404; A61K31/4468; A61K31/495; A61P3/06; A61P3/10; A61P9/10; C07D211/58; C07D241/04; C07D295/18; C07D295/22
Other References:
JPN6010069629, J.Med.Chem.,(1999),42(15),p.2741−6
JPN6010069630, Bull.Soc.Chim.Fr.,(1994),131,p.555−60
JPN6010069631, J.Org.Chem.,64(7),p.2579−81
JPN6010069632, Tetrahedron,(1968),24,p.7−11
JPN6010069633, Angew.Chem.,(1981),93(1),p.125−6
JPN6010069634, Angew.Chem.,(1979),91(1),p.72−3
JPN7010003983, Beilstein Online,BRN=1251851
Attorney, Agent or Firm:
Kazuo Shamoto (5 outside)